Clinical Trial Update: Outcome and Safety of Intermittent Dobutamine Infusion at a Day-Care Center in Advanced Heart Failure Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the outcomes and safety of intermittent dobutamine infusions in advanced heart failure patients treated at a day-care center.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Dobutamine (dobutamine)

Snippet

Sponsor: Sheba Medical Center | Conditions: Heart Failure | Phase 4 | Status: UNKNOWN